Tutoriales en YouTube para una educación musical desde la guitarra flamenca

114 páginas.Trabajo de Máster Oficial Interuniversitario en Comunicación y Educación Audiovisual. Directora: Ana Duarte Hueros ; Tutora: Ana García-Valcárcel Muñoz Repiso. El aprendizaje del flamenco desde los vídeos alojados en youtube está cada vez más extendido, convirtiéndose en una realidad que se ha instaurado en los procesos de enseñanza y aprendizaje sin seguir una planificación previa, surgiendo como resultado de las necesidades de la gente de un modo natural. Este trabajo presenta un análisis de este proceso a partir de la evaluación de un catálogo de vídeos didácticos de Guitarra Flamenca obtenidos de dicha plataforma. Para este análisis, se persiguen una serie de objetivos, entre los que se encuentran la comprobación de la calidad de los materiales encontrados en youtube para el aprendizaje de la guitarra flamenca, la comprobación de la aceptación social de la información contenida en la red, la revisión de diversas directrices para la evaluación de vídeos didácticos, la comprobación de las posibilidades didácticas de los video-tutoriales, y la revisión de los roles del alumnado y el profesorado en la elaboración de materiales didácticos

Session D7: Fishway with Two Entrance Locations: Understanding its importance for Iberian Barbel

Abstract In recent years, in the Iberian Peninsula, many fish passes have been built and improved. To ensure the proper operation of these, it is essential to carry out an evaluation and subsequent monitoring, considering both biologic and hydraulic aspects. We analyze the performance of Iberian barbel –Luciobarbus bocagei (Steindachner, 1864)– in a technical fishway: pool and weir, with bottom orifice. It is located in the Josefina hydropower plant (Duero River, Valladolid, Spain). Fish ladder has two fish entrances: one in the turbine outlet channel and another in the natural river course. Both the most relevant hydraulic values (flow, velocity, volumetric energy dissipation) and biological parameters (movement pattern, attraction, entry and passage) were measured. Biological assessment was conducted in the spawning season using PIT tag technology. The main influence on upstream movement was river discharge. There were no preferences between path selection; and ascent success and transit time were similar between two entrances.. Results highlight the importance of two access points for improve entrance and decrease migration delay

UPMSat-2 Micro-Satellite: In-orbit Technological Demonstration for Education and Science

The UPMSat-2 micro-satellite was launched on September the 3rd 2020 at 01:51:10 UTC from Kourou spaceport in French Guyana. The VV16 Vega Flight has been the first low Earth orbit rideshare commercial flight with a total of 53 satellites (7 of them micro-satellites) to be released by the launch vehicle, arranged in the modular SSMS (Small Spacecraft Mission Service) dispenser. UPMSat-2 is an educational, scientific and in-orbit technological demonstration microsatellite project led by the IDR/UPM research institute from Universidad Politécnica de Madrid (UPM), Spain. This mission can be considered as a logical extension of the IDR/UPM Institute activities focused on designing small satellites to be used as educational platforms of first level. Thereby, UPMSat-2 (as well as its precursor, the UPMSat-1) has the main objective to give students the competences for designing, analyzing, manufacturing, integrating, testing and operating the platform. UPMSat-2 also includes a set of scientific payloads and equipment to be tested in space, provided by research institutions and private companies. The UPMSat-2 is a 50 kg-class microsatellite developed for a 2-year LEO mission with a geometrical envelope of 0.5 x 0.5 x 0.6 m. Since launch, the satellite is orbiting the Earth in a sun-synchronous orbit of 500 km of altitude, passing over the IDR/UPM ground station four times a day. The satellite operation is being carried out by students and professors of the Master in Space Systems (MUSE), an official Master’s program of UPM organized by IDR/UPM. This work describes the most relevant characteristics of UPMSat-2, its payloads, technological contributions, and the main activities performed up to the launch, including participation in the launch campaign in French Guyana. The lessons learned during the mission are also summarized. Finally, the importance and benefits of incorporating actual space systems design and development within academic programs is also emphasized, as it improves these programs with constant and direct feedback

Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain : OSIREX-Spanish Lung Cancer Group

AURA study reported 61% objective response rate and progression-free survival of 9.6 months with osimertinib in patients with EGFR/T790M+ non-small cell lung cancer. Due to lack of real-world data, we proposed this study to describe the experience with osimertinib in Spain. Post-authorization, non-interventional Special Use Medication Program, multicenter, retrospective study in advanced EGFR/T790M+ non-small cell lung cancer. One hundred-fifty five patients were enrolled (August 2016-December 2018) from 30 sites. Primary objective: progression-free survival. Secondary objectives: toxicity profile, objective response rate, and use of health service resources. 70% women, median age 66. 63.9% were non-smokers and 99% had adenocarcinoma. Most patients had received at least one prior treatment (97%), 91.7% had received previous EGFR-tyrosine kinase inhibitors and 2.8% osimertinib as first-line treatment. At data cutoff, median follow-up was 11.8 months. One hundred-fifty five patients were evaluable for response, 1.3% complete response, 40.6% partial response, 31% stable disease and 11.6% disease progression. Objective response rate was 42%. Median progression-free survival was 9.4 months. Of the 155 patients who received treatment, 76 (49%) did not reported any adverse event, 51% presented some adverse event, most of which were grade 1 or 2. The resource cost study indicates early use is warranted. This study to assess the real-world clinical impact of osimertinib showed high drug activity in pretreated advanced EGFR/T790M+ non-small cell lung cancer, with manageable adverse events. Clinical trial registration number : NCT03790397

Perspectivas actuales de los sujetos de derecho

En este volumen se recogen las intervenciones del II Seminario Internacional Permanente del Departamento de Derecho Internacional, Eclesiástico y Filosofía del Derecho de la Universidad Carlos III de Madrid que se desarrolló en el curso académico 2010-2011Presentación / Rafael de Asís Roig. - Algunas reflexiones sobre el individuo en Derecho Internacional / Castor Díaz Barrado. - Sobre capacidad y derechos / Rafael de Asís Roig. - Derecho Común versus Derecho Especial : el individuo como sujeto del derecho de libertad de conciencia y religiosa en España y Portugal / Alejandro Torres Gutiérrez. - Las empresas transnacionales como actores y sujetos «potenciales» en la sociedad internacional / Romualdo Bermejo García. - Las minorías religiosas como sujetos de derechos en España : un sistema de desigualdad / José María Contreras Mazario. - Los colectivos como sujetos de Derecho / Olga Sánchez Martínez. - De «protectorado internacional» a Estado «protegido» (¿Es Kosovo un Estado?) / Cesáreo Gutiérrez Espada - Contra el Derecho Internacional : imperialismo americano y subjetividad jurídica / Cristina García Pascual. - Cooperación constitucional e internacionalidad de la Iglesia católica / Paulino Pardo Prieto. - El individuo como titular de la libertad religiosa : aproximación a un problema de filosofía jurídica / Fernando Arlettaz. - La adopción de un procedimiento de comunicaciones individuales : ¿asignatura pendiente en la consolidación de la «subjetividad internacional del niño»? / Mª del Rosario Carmona Luque. - La persona con discapacidad como sujeto de derechos : análisis desde dos modelos / Patricia Cuenca Gómez. - Los sujetos de Derecho Internacional y los desastres internacionales / Carlos R. Fernández Liesa. - Los inmigrantes como colectivo : ¿son sujeto de Derecho Internacional? / Rosana Garciandía Garmendia. - La empresa : ¿Sujeto de Derecho Internacional? : Importancia de la cuestión / Hilda Garrido Suárez. - La tolerancia étnica y religiosa en los proyectos para la independencia del Estado búlgaro de la dominación otomana, el punto de partida del concepto legal sobre la protección de los derechos fundamentales de las minorias en Bulgaria / Ángel Hristov Kolev. - El régimen jurídico del profesorado y de la asignatura de religión católica en la escuela pública. Comentario a la STC 51/2011 de 14 de abril / Andrés Murcia González. - El sujeto de derecho en Pufendorf / Antonio Pele. - ¿Puede un sujeto de Derecho Internacional juzgar a otro? Algunas consideraciones sobre la inmunidad de jurisdicción de las organizaciones internacionales / Juan Jorge Piernas Lópe

Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia:the PETHEMA-PALG experience

The most important challenges in acute promyelocytic leukemia (APL) is preventing early death and reducing long-term events, such as second neoplasms (s-NPLs). We performed a retrospective analysis of 2670 unselected APL patients, treated with PETHEMA “chemotherapy based” and “chemotherapy free” protocols. Only de novo APL patients who achieved complete remission (CR) and completed the three consolidation cycles were enrolled into the analysis. Out of 2670 APL patients, there were 118 (4.4%) who developed s-NPLs with the median latency period (between first CR and diagnosis of s-NPL) of 48.0 months (range 2.8–231.1): 43.3 (range: 2.8–113.9) for s-MDS/AML and 61.7 (range: 7.1–231.1) for solid tumour. The 5-year CI of all s-NPLs was of 4.43% and 10 years of 7.92%. Among s-NPLs, there were 58 cases of s-MDS/AML, 3 cases of other hematological neoplasms, 57 solid tumours and 1 non-identified neoplasm. The most frequent solid tumour was colorectal, lung and breast cancer. Overall, the 2-year OS from diagnosis of s-NPLs was 40.6%, with a median OS of 11.1 months. Multivariate analysis identified age of 35 years (hazard ratio = 0.2584; p &lt; 0.0001) as an independent prognostic factor for s-NPLs. There were no significant differences in CI of s-NPLs at 5 years between chemotherapy-based vs chemotherapy-free regimens (hazard ratio = 1.09; p = 0.932). Larger series with longer follow-up are required to confirm the potential impact of ATO+ATRA regimens to reduce the incidence of s-NPLs after front-line therapy for APL.</p

A primary healthcare information intervention for communicating cardiovascular risk to patients with poorly controlled hypertension: The Education and Coronary Risk Evaluation (Educore) study-A pragmatic, cluster-randomized trial

PURPOSE: Uncertainty exists regarding the best way to communicate cardiovascular risk (CVR) to patients, and it is unclear whether the comprehension and perception of CVR varies according to the format used. The aim of the present work was to determine whether a strategy designed for communicating CVR information to patients with poorly controlled high blood pressure (HBP), but with no background of cardiovascular disease, was more effective than usual care in the control of blood pressure (BP) over the course of a year. METHODS: A pragmatic, two-arm, cluster-randomized controlled trial was performed. Consecutive patients aged 40-65 years, all diagnosed with HBP in the last 12 months, and all of whom showed poor control of their condition (systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg), were recruited at 22 primary healthcare centres. Eleven centres were randomly assigned to the usual care arm, and 11 to the informative intervention arm (Educore arm). At the start of the study, the Educore arm subjects were shown the "low risk SCORE table", along with impacting images and information pamphlets encouraging the maintenance of good cardiovascular health. The main outcome variable measured was the control of HBP; the secondary outcome variables were SCORE table score, total plasma cholesterol concentration, use of tobacco, adherence to prescribed treatment, and quality of life. RESULTS: The study participants were 411 patients (185 in the Educore arm and 226 in the usual care arm). Multilevel logistic regression showed that, at 12 months, the Educore intervention achieved better control of HBP (OR = 1.57; 1.02 to 2.41). No statistically significant differences were seen between the two arms at 12 months with respect to the secondary outcomes. CONCLUSIONS: Compared to usual care, the Educore intervention was associated with better control of HBP after adjusting for age, baseline SBP and plasma cholesterol, at 12 months.This study was funded by the Spanish Ministry of Science and Innovation via the Instituto de Salud Carlos III, Subprograma de Proyectos de Investigación en Evaluación de Tecnologías Sanitarias y Servicios de Salud (PI 09/90354), and the Fundación de Investigación e Innovación Biomédica en Atención Primaria (FIIBAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscriptS

Impact of the first wave of the SARS-CoV-2 pandemic on the outcome of neurosurgical patients: A nationwide study in Spain

Objective To assess the effect of the first wave of the SARS-CoV-2 pandemic on the outcome of neurosurgical patients in Spain. Settings The initial flood of COVID-19 patients overwhelmed an unprepared healthcare system. Different measures were taken to deal with this overburden. The effect of these measures on neurosurgical patients, as well as the effect of COVID-19 itself, has not been thoroughly studied. Participants This was a multicentre, nationwide, observational retrospective study of patients who underwent any neurosurgical operation from March to July 2020. Interventions An exploratory factorial analysis was performed to select the most relevant variables of the sample. Primary and secondary outcome measures Univariate and multivariate analyses were performed to identify independent predictors of mortality and postoperative SARS-CoV-2 infection. Results Sixteen hospitals registered 1677 operated patients. The overall mortality was 6.4%, and 2.9% (44 patients) suffered a perioperative SARS-CoV-2 infection. Of those infections, 24 were diagnosed postoperatively. Age (OR 1.05), perioperative SARS-CoV-2 infection (OR 4.7), community COVID-19 incidence (cases/10 5 people/week) (OR 1.006), postoperative neurological worsening (OR 5.9), postoperative need for airway support (OR 5.38), ASA grade =3 (OR 2.5) and preoperative GCS 3-8 (OR 2.82) were independently associated with mortality. For SARS-CoV-2 postoperative infection, screening swab test <72 hours preoperatively (OR 0.76), community COVID-19 incidence (cases/10 5 people/week) (OR 1.011), preoperative cognitive impairment (OR 2.784), postoperative sepsis (OR 3.807) and an absence of postoperative complications (OR 0.188) were independently associated. Conclusions Perioperative SARS-CoV-2 infection in neurosurgical patients was associated with an increase in mortality by almost fivefold. Community COVID-19 incidence (cases/10 5 people/week) was a statistically independent predictor of mortality. Trial registration number CEIM 20/217